JP2018521992A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018521992A5 JP2018521992A5 JP2017565934A JP2017565934A JP2018521992A5 JP 2018521992 A5 JP2018521992 A5 JP 2018521992A5 JP 2017565934 A JP2017565934 A JP 2017565934A JP 2017565934 A JP2017565934 A JP 2017565934A JP 2018521992 A5 JP2018521992 A5 JP 2018521992A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- wiping
- skin
- cloth
- applying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims description 71
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 26
- 210000003491 skin Anatomy 0.000 claims description 23
- 235000011399 aloe vera Nutrition 0.000 claims description 17
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 13
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 13
- 229960000458 allantoin Drugs 0.000 claims description 13
- 210000001519 tissue Anatomy 0.000 claims description 13
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 11
- 229920002498 Beta-glucan Polymers 0.000 claims description 11
- 244000144927 Aloe barbadensis Species 0.000 claims description 10
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 229930003427 Vitamin E Natural products 0.000 claims description 8
- 239000003974 emollient agent Substances 0.000 claims description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- 229940046009 vitamin E Drugs 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 230000000845 anti-microbial effect Effects 0.000 claims description 7
- 239000003623 enhancer Substances 0.000 claims description 7
- 210000000987 immune system Anatomy 0.000 claims description 7
- 238000010521 absorption reaction Methods 0.000 claims description 6
- 239000003906 humectant Substances 0.000 claims description 6
- 229940123457 Free radical scavenger Drugs 0.000 claims description 5
- 210000004400 mucous membrane Anatomy 0.000 claims description 5
- 210000002640 perineum Anatomy 0.000 claims description 5
- 239000002516 radical scavenger Substances 0.000 claims description 5
- 240000000560 Citrus x paradisi Species 0.000 claims description 4
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 4
- 230000010261 cell growth Effects 0.000 claims description 4
- 230000005855 radiation Effects 0.000 claims description 4
- 210000000434 stratum corneum Anatomy 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 239000004599 antimicrobial Substances 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 230000035876 healing Effects 0.000 claims description 3
- 208000015181 infectious disease Diseases 0.000 claims description 3
- 230000003020 moisturizing effect Effects 0.000 claims description 3
- -1 polyphenol compounds Chemical class 0.000 claims description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 2
- 239000002518 antifoaming agent Substances 0.000 claims description 2
- 229920002770 condensed tannin Polymers 0.000 claims description 2
- 230000002708 enhancing effect Effects 0.000 claims description 2
- 230000007760 free radical scavenging Effects 0.000 claims description 2
- 229940087603 grape seed extract Drugs 0.000 claims description 2
- 235000002532 grape seed extract Nutrition 0.000 claims description 2
- 239000007952 growth promoter Substances 0.000 claims description 2
- 235000018192 pine bark supplement Nutrition 0.000 claims description 2
- 235000013824 polyphenols Nutrition 0.000 claims description 2
- 229940106796 pycnogenol Drugs 0.000 claims description 2
- 239000001717 vitis vinifera seed extract Substances 0.000 claims description 2
- 239000004744 fabric Substances 0.000 claims 17
- 210000001099 axilla Anatomy 0.000 claims 5
- 210000003205 muscle Anatomy 0.000 claims 5
- 210000002414 leg Anatomy 0.000 claims 4
- 206010010904 Convulsion Diseases 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 3
- 230000017531 blood circulation Effects 0.000 claims 3
- 230000036461 convulsion Effects 0.000 claims 3
- 230000002503 metabolic effect Effects 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- 239000002699 waste material Substances 0.000 claims 3
- 208000034656 Contusions Diseases 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 230000036512 infertility Effects 0.000 claims 2
- 230000001954 sterilising effect Effects 0.000 claims 2
- 238000004659 sterilization and disinfection Methods 0.000 claims 2
- 210000002700 urine Anatomy 0.000 claims 2
- 206010073306 Exposure to radiation Diseases 0.000 claims 1
- 206010021639 Incontinence Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 206010070757 Muscle contusion Diseases 0.000 claims 1
- 206010049816 Muscle tightness Diseases 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 229940093797 bioflavonoids Drugs 0.000 claims 1
- 210000001217 buttock Anatomy 0.000 claims 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 claims 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 claims 1
- 238000011109 contamination Methods 0.000 claims 1
- 230000009519 contusion Effects 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 239000012678 infectious agent Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 230000007774 longterm Effects 0.000 claims 1
- 210000004877 mucosa Anatomy 0.000 claims 1
- 230000001937 non-anti-biotic effect Effects 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 201000000195 skin tag Diseases 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 238000010792 warming Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 241001116389 Aloe Species 0.000 description 7
- 229940008099 dimethicone Drugs 0.000 description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 6
- 229940065115 grapefruit extract Drugs 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 2
- 229940116224 behenate Drugs 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 239000010374 citricidal Substances 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 230000003254 anti-foaming effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000656 anti-yeast Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 239000013530 defoamer Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000000899 immune system response Effects 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000015227 regulation of liquid surface tension Effects 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical group O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/745,091 | 2015-06-19 | ||
| US14/745,091 US20160158393A1 (en) | 2014-02-21 | 2015-06-19 | Method for Improving Health Outcomes |
| PCT/US2016/038043 WO2016205620A1 (en) | 2015-06-19 | 2016-06-17 | Method for improving health outcomes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018521992A JP2018521992A (ja) | 2018-08-09 |
| JP2018521992A5 true JP2018521992A5 (enExample) | 2019-08-15 |
Family
ID=56464282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017565934A Pending JP2018521992A (ja) | 2015-06-19 | 2016-06-17 | 健康アウトカムを改善するための方法 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP3310443A1 (enExample) |
| JP (1) | JP2018521992A (enExample) |
| BR (1) | BR112017027349B1 (enExample) |
| CA (1) | CA2989644A1 (enExample) |
| MX (2) | MX2017016911A (enExample) |
| WO (2) | WO2016205620A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10046137B2 (en) | 2014-02-21 | 2018-08-14 | Avadim Technologies, Inc. | Method for maintenance of urethral catheters |
| CN107693457A (zh) * | 2017-11-16 | 2018-02-16 | 东兴市良佳优农林科技有限公司 | 止痒洗发露 |
| CN107737070A (zh) * | 2017-11-16 | 2018-02-27 | 东兴市良佳优农林科技有限公司 | 杀菌、护肤洗手液 |
| EP3982909A4 (en) | 2019-06-12 | 2023-11-29 | Avadim Health, Inc. | COMPOSITIONS AND METHODS FOR ANTISEPTIC TREATMENT OF BIOFILMS ON MAMMALIAN TISSUE |
| JP2021155362A (ja) * | 2020-03-27 | 2021-10-07 | 株式会社ナリス化粧品 | ペルオキシナイトライト活性阻害方法および、ペルオキシナイトライト活性阻害剤のスクリーニング方法 |
| JP2021159046A (ja) * | 2020-04-03 | 2021-10-11 | 花王株式会社 | 皮膚情報提供方法 |
| IT202000021634A1 (it) * | 2020-09-16 | 2020-12-16 | Prete Antonio Del | Dispositivo per la somministrazione di una soluzione con iodiopovidone per la prevenzione delle infezioni dell'occhio |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995023009A1 (en) * | 1994-02-28 | 1995-08-31 | Incline Technologies, Inc. | Method and system for cleansing the skin |
| US6358516B1 (en) | 1998-08-21 | 2002-03-19 | Norris R. Harod | One-step system for cleansing, conditioning, and treating the skin |
| EP2563356A4 (en) * | 2010-04-27 | 2013-10-16 | St John S Medical Res Inst | COMPOSITION FOR SKIN CARE AND PROTECTION AND METHOD OF USE THEREOF |
| US9327029B2 (en) * | 2011-05-05 | 2016-05-03 | Celacare Technologies, Llc | Antimicrobial silver hydrogel composition for the treatment of burns and wounds |
-
2016
- 2016-06-17 CA CA2989644A patent/CA2989644A1/en active Pending
- 2016-06-17 JP JP2017565934A patent/JP2018521992A/ja active Pending
- 2016-06-17 WO PCT/US2016/038043 patent/WO2016205620A1/en not_active Ceased
- 2016-06-17 BR BR112017027349-7A patent/BR112017027349B1/pt active IP Right Grant
- 2016-06-17 EP EP16741722.9A patent/EP3310443A1/en active Pending
- 2016-06-17 MX MX2017016911A patent/MX2017016911A/es unknown
- 2016-06-20 WO PCT/US2016/038409 patent/WO2016205812A1/en not_active Ceased
-
2017
- 2017-12-19 MX MX2022005561A patent/MX2022005561A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101687002B (zh) | 葫芦巴的提取物 | |
| JP6495183B2 (ja) | 表面の創傷を処置するための組成物および方法 | |
| JP2019135266A (ja) | 抗微生物性組成物とその使用方法 | |
| US20110071105A1 (en) | Wound-healing pharmaceutical compositions in the form of a cream based on amino acids and sodium hyaluronate | |
| BRPI0609429A2 (pt) | Uso de uma solução aquosa com potencial redutivo oxidativo (orp) | |
| EP2563356A2 (en) | A composition for skin sanitization and protection and method of its use | |
| US20100284951A1 (en) | Novel compositions for the treatment of wounds and skin care | |
| CN109646712B (zh) | 一种胶态硫液体敷料及其制备方法 | |
| CN105232443A (zh) | 一种天然植物抗过敏化妆水及其制备方法和应用 | |
| CA2608344C (en) | Method and composition for use in preparation of a patient for surgery | |
| JP2018521992A (ja) | 健康アウトカムを改善するための方法 | |
| CN102614113A (zh) | 复合免洗消毒凝胶 | |
| CN105767049A (zh) | 一种动物用消毒液 | |
| CN105709273A (zh) | 一种含聚乙二醇的液体医用敷料 | |
| RU2416425C1 (ru) | Масло противопролежневое | |
| US7438937B2 (en) | Topical burn composition containing Mentha haplocalyx and one or both of Aloe vera and recombinant human epidermal growth factor | |
| CN103735481A (zh) | 一种抗菌消炎漱口水及其制备方法 | |
| CN108743911A (zh) | 一种灭菌养护剂 | |
| RU2326651C1 (ru) | Лечебно-косметический крем для ухода ног | |
| RU2002111873A (ru) | Способ лечения акне | |
| CN104055720A (zh) | 止痒护肤水 | |
| KR101447951B1 (ko) | 아토 케어 힐링 볼 및 그 제조방법 | |
| EP3498261B1 (en) | Composition comprising zinc and surfactants for use in removing bacterial biofilms and treating tissues | |
| CN106138143A (zh) | 纯中药烧烫伤、褥疮液及其制备方法 | |
| CN100450505C (zh) | 一种治疗脚气病的中药脚气膏 |